News | May 30, 2022
North India’s first biotech park at Kathua, J&K inaugurated
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
Objective tracking data combined with cohort data to drive medicine of the future
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins
Subscribe To Our Newsletter & Stay Updated
